Death Following Creatine Kinase-MB Elevation After Coronary Intervention
Open Access
- 3 September 2002
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 106 (10), 1205-1210
- https://doi.org/10.1161/01.cir.0000028146.71416.2e
Abstract
Background— Creatine kinase (CK)-MB elevation after percutaneous coronary intervention (PCI) has been associated with subsequent cardiac death. The patients at risk, the timing of risk, and potential treatment implications are uncertain. Methods and Results— Eight thousand, four hundred nine consecutive non– acute myocardial infarction patients with successful PCI and no emergency surgery or Q-wave myocardial infarction were followed for 38±25 months; 1446 (17.2%) had post-PCI CK-MB above normal on routine ascertainment. Patients were prospectively stratified into those with CK-MB 1 to 5× or CK-MB >5× normal. No patient with CK-MB 1 to 5× normal died during the first week after PCI, and excess risk of early death for patients with CK-MB elevation occurred primarily in the first 3 to 4 months. The actuarial 4-month risk of death was 8.9%, 1.9%, and 1.2% for patients with CK-MB >5×, CK-MB 1 to 5×, and CK-MB ≤1× normal ( P P P P =0.005), and no statin treatment at hospital discharge ( P =0.009) were associated with death. Conclusions— Patients with CK-MB elevation after PCI are at excess risk of death for 3 to 4 months, although prolonging hospitalization for CK-MB 1 to 5× is unlikely to modify risk. CK-MB >5× normal, incomplete revascularization, elevated C-reactive protein, heart failure, the elderly, and hospital discharge without on statin therapy increases risk. Several of these factors suggest that inflammation may play a part in the excess risk of death.Keywords
This publication has 10 references indexed in Scilit:
- Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stentingThe American Journal of Cardiology, 2002
- Prognostic value of cardiac troponin-I levels following catheter-based coronary interventionsThe American Journal of Cardiology, 2000
- Long-term clinical events following creatine kinase–myocardial band isoenzyme elevation after successful coronary stentingJournal of the American College of Cardiology, 2000
- Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary interventionJournal of the American College of Cardiology, 1999
- Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous interventionJournal of the American College of Cardiology, 1999
- Asymmetrical effects of angiographically assessed collateral flow on vasodilator and exercise stress-induced ischemiaJournal of the American College of Cardiology, 1998
- Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor managementJournal of the American College of Cardiology, 1996
- Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stentingThe American Journal of Cardiology, 1994
- Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty?Journal of the American College of Cardiology, 1993
- IntroductionThe American Journal of Cardiology, 1991